EMPRISE
Live / Registered — Registered — Section 71 accepted (as of 27 May 2025)
What this means for you
Registered since 29 Jan 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Jan 2029: the §71 ten-year affidavit of use).
Record
- Serial number
- 79229786
- Registration number
- 5663596
- Mark type
- Word mark
- Filed
- 21 Dec 2017
- Published for opposition
- 13 Nov 2018
- Registered
- 29 Jan 2019
- Next maintenance filing
- §71 ten-year affidavit of use, due by 29 Jan 2029 (grace period to 29 Jul 2029)
- Attorney of record
- Max Moskowitz
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
Prosecution history
- 27 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 27 May 2025 — REGISTERED-SEC.71 ACCEPTED
- 26 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Jan 2025 — TEAS SECTION 71 RECEIVED
- 29 Jan 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 14 Jun 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 May 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 23 May 2019 — FINAL DISPOSITION PROCESSED
- 29 Apr 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 29 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Nov 2018 — PUBLISHED FOR OPPOSITION
- 09 Nov 2018 — NOTIFICATION PROCESSED BY IB
- 24 Oct 2018 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 24 Oct 2018 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB